Drug Information

Drug General Information
Drug ID
D02MUA
Former ID
DIB010716
Drug Name
PF-06439535
Drug Type
Antibody
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [524593]
Company
Pfizer
Target and Pathway
Target(s) VEGF ligand Target Info [550401]
References
Ref 524593ClinicalTrials.gov (NCT02031991) A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01). U.S. National Institutes of Health.
Ref 550401National Cancer Institute Drug Dictionary (drug id 43234).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.